Back
ESC Premium Access

Prognostic implication of sodium nitroprusside vasodilator test in pulmonary hypertension and left heart disease: insights from PUSHON registry.

Session: The Conundrum of Pulmonary Hypertension due to Left Heart Disease – Can Science Help?
Topic: Pulmonary Hypertension
Speaker: Doctor P. Boretto (Turin, IT)
Event: ESC Congress 2020

Congress Presentation

Add to my library

Like

About the speaker

Doctor Paolo Boretto

University of Turin, Turin (Italy)
0 follower

5 more presentations in this session

Combined pre- and post-capillary pulmonary hypertension defined by new criteria is worse prognosis group in patients with heart failure

Speaker: Doctor T. Ibe (Saitama, JP)

Access
Abstract
Slides
Like
Thumbnail

Prognostic role of comorbidities in patients with pulmonary arterial hypertension

Speaker: Doctor A. De Lorenzis (Bologna, IT)

Access
Abstract
Slides
Like
Thumbnail

Clinical characteristics and prognostic impact of pulmonary hypertension in heart failure with preserved ejection fraction: the PURSUIT HFpEF study

Speaker: Doctor F. Sera (Suita, JP)

Access
Abstract
Slides
Like
Thumbnail

The association between atrial fibrillation and pulmonary embolism

Speaker: Doctor E. Svennberg (Stockholm, SE)

Access
Abstract
Slides
Like
Thumbnail

Modeling survival using decision tree analysis in pulmonary hypertension due to left heart disease. the prognostic significance of PVR < 3WU when TAPSE < 16mm

Speaker: Mr C. Fauvel (Rouen, FR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

The Conundrum of Pulmonary Hypertension due to Left Heart Disease – Can Science Help?

Speakers: Doctor P. Boretto, Doctor T. Ibe, Doctor A. De Lorenzis, Doctor F. Sera, Doctor E. Svennberg...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources